<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
 <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
 <link rel="stylesheet" type="text/css" href="anti-diabetic%20drug%20pathway/savehtml.css"/>
 <title>anti-diabetic drug pathway
 </title>
</head>
<body>
 <div class="pw">
  <map id="pwmap" name="pwmap">
   <area href="http://www.ariadnegenomics.com" target="AGI_SUMMARY" alt="Ariadne Genomics Inc." coords="731,518,821,548"/>
   <area href="anti-diabetic%20drug%20pathway/145701.html" target="AGI_SUMMARY" alt="type 2 diabetes mellitus" coords="479,33,579,71"/>
   <area href="anti-diabetic%20drug%20pathway/22009.html" target="AGI_SUMMARY" alt="repaglinide" coords="457,246,571,291"/>
   <area href="anti-diabetic%20drug%20pathway/23593.html" target="AGI_SUMMARY" alt="nateglinide" coords="211,240,315,285"/>
   <area href="anti-diabetic%20drug%20pathway/145689.html" target="AGI_SUMMARY" alt="repaglinide pharmacokinetics pathway" coords="400,433,554,488"/>
   <area href="anti-diabetic%20drug%20pathway/145688.html" target="AGI_SUMMARY" alt="nateglinide pharmacokinetics pathway" coords="232,434,386,488"/>
   <area href="anti-diabetic%20drug%20pathway/1001404725.html" target="AGI_SUMMARY" alt="nateglinide ---&gt; potassium channel inhibitors pharmacodynamics pathway" coords="356,222,366,232"/>
   <area href="anti-diabetic%20drug%20pathway/1001404724.html" target="AGI_SUMMARY" alt="repaglinide ---&gt; repaglinide pharmacokinetics pathway" coords="381,336,391,346"/>
   <area href="anti-diabetic%20drug%20pathway/1001404723.html" target="AGI_SUMMARY" alt="nateglinide ---&gt; nateglinide pharmacokinetics pathway" coords="361,336,371,346"/>
   <area href="anti-diabetic%20drug%20pathway/1001404726.html" target="AGI_SUMMARY" alt="repaglinide ---&gt; potassium channel inhibitors pharmacodynamics pathway" coords="408,220,418,230"/>
   <area href="anti-diabetic%20drug%20pathway/145687.html" target="AGI_SUMMARY" alt="insulin secretion pathway" coords="123,44,216,83"/>
   <area href="anti-diabetic%20drug%20pathway/1001404735.html" target="AGI_SUMMARY" alt="potassium channel inhibitors pharmacodynamics pathway --+&gt; insulin secretion pathway" coords="284,73,294,83"/>
   <area href="anti-diabetic%20drug%20pathway/145686.html" target="AGI_SUMMARY" alt="potassium channel inhibitors pharmacodynamics pathway" coords="326,93,451,156"/>
   <area href="anti-diabetic%20drug%20pathway/1001404908.html" target="AGI_SUMMARY" alt="potassium channel inhibitors pharmacodynamics pathway ---| type 2 diabetes mellitus pathway" coords="400,45,410,55"/>
   <area href="anti-diabetic%20drug%20pathway/1001404736.html" target="AGI_SUMMARY" alt="potassium channel inhibitors pharmacodynamics pathway ---| type 2 diabetes mellitus" coords="399,46,409,56"/>
   <area href="anti-diabetic%20drug%20pathway/145801.html" target="AGI_SUMMARY" alt="type 2 diabetes mellitus pathway" coords="489,0,584,37"/>
  </map>
  <img id="pwimg" src="anti-diabetic%20drug%20pathway/pwmap.png" usemap="#pwmap" alt="" border="0"/>
 </div>
</body>
</html>